Summary:
GUWAHATI: The Indian Institute of Technology Guwahati is collaborating with Hester Biosciences Limited, a pharmaceutical company based in Ahmedabad, Gujarat, to work on the vaccine development against COVID-19. The vaccine will be based on recombinant avian paramyxovirus based vector platform. The team has generated the recombinant avian paramyxovirus-1 based vaccine flatform for Classical Swine Fever and Japanese encephalitis. The role of the Institute is to produce the recombinant vaccine candidate. IITG & Hester have collaborated to develop and manufacture a recombinant vaccine against COVID-19 disease as a preventive measure..